A phase III, randomized, double-blind, placebo-controlled, study of iseganan for the reduction of stomatitis in patients receiving stomatotoxic chemotherapy

  • Francis J. Giles
  • , Roberto Rodriguez
  • , Daniel Weisdorf
  • , John R. Wingard
  • , Paul J. Martin
  • , Thomas R. Fleming
  • , Stuart L. Goldberg
  • , Elias J. Anaissie
  • , Brian J. Bolwell
  • , Nelson J. Chao
  • , Thomas C. Shea
  • , Mark M. Brunvand
  • , William Vaughan
  • , Finn Petersen
  • , Mark Schubert
  • , Hillard M. Lazarus
  • , Richard T. Maziarz
  • , Margarida Silverman
  • , Roy A. Beveridge
  • , Rebecca Redman
    • Janis G. Pulliam, Patricia Devitt-Risse, Henry J. Fuchs, David D. Hurd

Research output: Contribution to journal › Article › peer-review

70 Scopus citations

Fingerprint

Dive into the research topics of 'A phase III, randomized, double-blind, placebo-controlled, study of iseganan for the reduction of stomatitis in patients receiving stomatotoxic chemotherapy'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Medicine and Dentistry